Patient-Centricity: A Drug Development Imperative

By Michael Dennis, Director of Technical Operations, Science and Technology, AbbVie and Bill Huang, Sr. Principal Research Scientist, Formulation Sciences, AbbVie.

Success in the pharmaceutical industry is about more than the efficacy of compounds. It’s about facilitating positive patient outcomes. We know positive outcomes are in no small part dependent on the patient’s acceptance and administration of—and ultimately their experience with—the therapies we create. The connection between drug manufacturing and patient outcomes is not in question; but how much is patient-centricity influencing the process of therapy development today, and how much room does the industry have for further patient-centric improvement?